Discounted Cash Flow
CVS Health Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $177.5b | $5.3b | $7.8b | 3.0% | $4.93 |
| 2017 | $184.8b (4.1%) | $6.6b (24.5%) | $6.1b (-22.4%) | 3.6% (19.7%) | $6.47 (31.2%) |
| 2018 | $193.9b (5.0%) | $-594.0m (-109.0%) | $6.8b (12.1%) | -0.3% (-108.5%) | $-0.57 (-108.8%) |
| 2019 | $256.8b (32.4%) | $6.6b (1216.8%) | $10.4b (52.2%) | 2.6% (943.4%) | $5.10 (994.7%) |
| 2020 | $268.7b (4.6%) | $7.2b (8.2%) | $13.4b (29.2%) | 2.7% (3.4%) | $5.48 (7.5%) |
| 2021 | $292.1b (8.7%) | $7.9b (10.2%) | $15.7b (17.3%) | 2.7% (1.4%) | $6.00 (9.5%) |
| 2022 | $322.5b (10.4%) | $4.1b (-47.5%) | $13.4b (-14.6%) | 1.3% (-52.5%) | $3.16 (-47.3%) |
| 2023 | $357.8b (10.9%) | $8.3b (101.1%) | $10.4b (-22.7%) | 2.3% (81.3%) | $6.49 (105.4%) |
| 2024 | $372.8b (4.2%) | $4.6b (-44.7%) | $6.3b (-39.1%) | 1.2% (-46.9%) | $3.67 (-43.5%) |
| 2025 | $402.1b (7.8%) | $1.8b (-61.7%) | $7.8b (23.4%) | 0.4% (-64.5%) | $1.40 (-61.9%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.